Articles dans des revues avec comité de lecture (253)
  1. 95. El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., & Vaugeois, J.-M. (2008). Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine. Neuropharmacology, 55(1), 35-40. doi:10.1016/j.neuropharm.2008.04.007
  2. 96. Touriño, C., Ledent, C., Maldonado, R., & Valverde, O. (2008). CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement. Biological psychiatry, 63(11), 1030-1038. doi:10.1016/j.biopsych.2007.09.003
  3. 97. Ben Addi, A., Lefort, A., Hua, X., Libert, F., Communi, D., Ledent, C., Macours, P., Tilley, S. L., Boeynaems, J.-M., & Robaye, B. (2008). Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor. European Journal of Immunology, 38(6), 1610-1620. doi:10.1002/eji.200737781
  4. 98. Teng, B., Ledent, C., & Mustafa, S. J. (2008). Up-regulation of A2B adenosine receptor in A2A adenosine receptor knockout mouse coronary artery. Journal of Molecular and Cellular Cardiology, 44(5), 905-914. doi:10.1016/j.yjmcc.2008.03.003
  5. 99. Ribé, D., Sawbridge, D., Thakur, S., Hussey, M., Ledent, C., Kitchen, I., Hourani, S., & Li, J.-M. (2008). Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity. Free radical biology & medicine, 44(7), 1433-1442. doi:10.1016/j.freeradbiomed.2007.12.035
  6. 100. Aso, E., Ozaita, A., Valdizán, E. M., Ledent, C., Pazos, A., Maldonado, R., & Valverde, O. (2008). BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. Journal of neurochemistry, 105(2), 565-572. doi:10.1111/j.1471-4159.2007.05149.x
  7. 101. Németh, B., Ledent, C., Freund, T. F., & Hájos, N. (2008). CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2. Neuropharmacology, 54(1), 51-57. doi:10.1016/j.neuropharm.2007.07.003
  8. 102. Croxford, J. L., Pryce, G., Jackson, S. J., Ledent, C., Giovannoni, G., Pertwee, R. G., Yamamura, T., & Baker, D. (2008). Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis. Journal of neuroimmunology, 193(1-2), 120-129. doi:10.1016/j.jneuroim.2007.10.024
  9. 103. Tam, J., Trembovler, V., Di Marzo, V., Petrosino, S., Leo, G., Alexandrovich, A., Regev, E., Casap, N., Shteyer, A., Ledent, C., Karsak, M., Zimmer, A., Mechoulam, R., Yirmiya, R., Shohami, E., & Bab, I. (2008). The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. The FASEB journal, 22(1), 285-294. doi:10.1096/fj.06-7957com
  10. 104. Balázsa, T., Bíró, J., Gullai, N., Ledent, C., & Sperlágh, B. (2008). CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus. Neurochemistry international, 52(1-2), 95-102. doi:10.1016/j.neuint.2007.07.008
  11. 105. Mievis, S., Levivier, M., Vassart, G., Brotchi, J., Ledent, C., & Blum, D. (2007). Citicoline is not protective in experimental models of Huntington's disease. Neurobiology of aging, 28(12), 1944-1946. doi:10.1016/j.neurobiolaging.2006.09.011
  12. 106. Thiemann, G., Fletcher, B. C., Ledent, C., Molleman, A., & Hasenöhrl, R. U. (2007). The genetic versus pharmacological invalidation of the cannabinoid CB(1) receptor results in differential effects on 'non-associative' memory and forebrain monoamine concentrations in mice. Neurobiology of learning and memory, 88(4), 416-423. doi:10.1016/j.nlm.2007.07.013
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>